Read more about how TailorMed is removing financial barriers to patients accessing care and our lead investment in their latest $40M financing. We are excited to partner with the TailorMed team to further expand their affordability network and platform. Why we invested in TailorMed: https://lnkd.in/gMUhPuSv Press Release: https://lnkd.in/dDZB4eAp
关于我们
Windham Capital Partners is a New York City based growth equity firm focused on healthcare, with particular emphasis on therapeutic medical technology and digital health. We have a small, highly focused team of managers who enjoy close relationships with strategics, leading venture capital firms, and innovators and entrepreneurs in the healthcare industry.
- 网站
-
https://www.windhamvp.com
Windham Capital Partners的外部链接
- 所属行业
- 风险投资与私募股权管理人
- 规模
- 2-10 人
- 总部
- New York
- 类型
- 合营企业
- 创立
- 2006
地点
-
主要
获取路线
US，New York
Windham Capital Partners员工
动态
-
For a growing number of Americans, a serious diagnosis or unexpected trip to the emergency room can create a severe financial burden. About 72% of patients with household incomes under $40,000 would not immediately be able to afford a $500 unexpected medical bill and more than 100 million US adults struggle with healthcare debt. TailorMed is on a mission to address these issues and assist patients in accessing and adhering to high-cost medications, and Windham Capital Partners is excited to be a part of the journey, along with the incredible management team and investors (Israel (Srulik) Dvorsky, Gideon Jagermann, Providence Ventures, Citi, BrightEdge - American Cancer Society , UH Ventures, Samsung Next, Triventures, Almeda Ventures , Sanara , Ballad Ventures, UnityPoint Health, Bank Hapoalim ??? ???????, Bridges Fund Management Ltd., Inception Health). Thank you Axios and Claire Rychlewski for covering our lead investment into TailorMed's $40M financing. https://lnkd.in/e-_hUxN2
Exclusive: TailorMed raises $40M to alleviate medical cost burden
axios.com
-
Excited to share insights from our own Sarah Fox, who explores the challenges and opportunities in digital health innovation in her latest article for Market Pathways. As this sector grows, understanding new payment and reimbursement pathways is crucial to commercial success. Sarah shares key strategies for navigating these complexities and driving impact in healthcare. Learn more from her full article below. #DigitalHealth #HealthcareInnovation #MedTech
Digital health technologies comprise a variety of innovative products and services, including mobile health apps, wearable devices, telemedicine platforms, and software and devices that utilize artificial intelligence (#AI) and machine-learning (ML) algorithms to increase the precision, accuracy, and personalization of healthcare. These technologies have tremendous potential to transform #healthcare around the world by increasing access to care, improving adherence to treatments that enable better patient outcomes, reducing inefficiencies and costs, empowering individuals to take a more active role in their health, and delivering holistic care that can keep people healthy and reduce the risk of disease development and progression. Digital health innovation carries challenges not only in technology, but also in understanding new payment and reimbursement models for a broad range of products and services. Here are some keys to mastering these new #pathways and achieving commercial success in this space. By Sarah Fox, Windham Capital Partners: https://bit.ly/40F0zVM
-
-
We are excited to announce that Windham Capital Partners was named to Inc.’s Founder-Friendly Investors List, which honors the investment firms that have been recognized by founders as trusted partners. Windham is honored to be featured on this list, as we strive to continue to be more than just capital partners to the innovative and inspiring entrepreneurs and management teams we back.?All of us at Windham are excited to continue investing in founders who are pioneering innovations in healthcare. Windham Capital Partners named to Inc.'s Founder-Friendly List: https://lnkd.in/eEbjeteq Check out the list here: https://lnkd.in/ebhzF2Xq #investing #healthcare #healthtech #innovation
Founder-Friendly Investors 2024: A Brighter Market
inc.com
-
Congratulations to the Science Exchange team on their acquisition by Waud Capital Partners. This significant milestone allows the company to continue delivering value to customers, expand their product portfolio, and drive meaningful innovation in the life science industry. #innovation #healthtech
We are thrilled to announce that Science Exchange has been acquired by Waud Capital Partners, a leading growth-oriented private equity firm specializing in software, healthcare IT, and life sciences sectors! ?? This acquisition is a significant milestone for our business and one that positions us to deliver even more value to our customers, suppliers, and partners, and we couldn’t be more excited to enter this new chapter with the Waud Capital team. Our commitment to delivering exceptional service and value remains unwavering, and our day-to-day operations will remain unchanged. Elizabeth Iorns, Ph.D., our CEO & Co-Founder, Dan Knox, our COO & Co-Founder, and Tzlil Hadass, our Chief Revenue Officer, will continue to lead the way, ensuring continuity for customers and stakeholders. To our valued customers and suppliers, your partnership has been instrumental in getting us here, and we’re grateful for your trust and collaboration. We’re excited to continue working closely with you, driving even greater efficiency, innovation, and growth together. Our partnership with Waud Capital positions us to further expand our product portfolio, invest in cutting-edge technologies, and grow our global team, bringing even more value to #ResearchDevelopment, #procurement, #finance, and #compliance teams. Read more about what this means for Science Exchange and our exciting journey ahead in our full press release below. ?#ScienceExchange #WaudCapital #LifeSciences #Innovation #SupplierOrchestration #Procurement
-
-
We are pleased to have David Kereiakes, one of Windham’s Managing Partners, as a panelist at LSI Europe 2024 in a couple of weeks, where he will be discussing the medtech liquidity landscape. ? #LSIEurope2024 #medtech #innovation
-
-
Congratulations to Upward Health on placing in the Top 10 on the Inc. 5000 list and Number 1 for companies headquartered in New York State for the second year in a row! #Inc5000 #healthcare #innovation
We’re excited to announce that Upward Health has been ranked No. 6 on the 2024 Inc. 5000 list of the fastest-growing private companies in the United States! ?? As a two-time, top 10 honoree, we also claim the position of No. 1 for companies headquartered in the State of New York for the second consecutive year.????? ?? Read the full press release. Inc. Magazine #Inc5000 #UpwardHealth
Upward Health Ranks No. 6 on the 2024 Inc. 5000
businesswire.com
-
Thanks to all who attended our Family Office Evening Out in Little Italy, NYC last week. We learned about the history of the area including the mafia's influence, enjoyed a delightful dinner and spoke about Windham’s focus on investing at the intersection of healthcare and technology to improve patient outcomes,?increase access to quality care and overcome inefficiencies throughout the healthcare ecosystem. Please feel free to contact me with any follow up questions.?? #FamilyOffice #GrowthEquity #HealthCare?
-
-
Great insights from top medtech leaders in the industry, including our own Managing Partner, David Kereiakes. https://lnkd.in/gzF66xpC #healthcare #medtech #innovation
Last week, Henry Peck challenged 10 of the top investors in our industry to weigh the relative importance of "founder quality vs market opportunity" in their investment process and explain their rationale. The result is a must-read article for Medtech and Healthtech operators who are raising capital and want a look behind the curtain into venture capital decision-making. The full article “Balancing Act: How Do Investors Weigh Founders Versus Markets in Medtech and Healthtech Venture?” is available at the link below: https://lnkd.in/gzF66xpC Thank you to our guest contributors to this article: ? Dr. Luc Marengere, Managing Partner at TVM Capital Life Science ? Dr. Gal Noyman - Veksler, Partner at LionBird ? Soyoung Park, General Partner at 1004 Venture Partners, Venture Partner at VU Venture Partners ? Armen Vidian, Founder and Managing Partner at Recode Ventures ? Adam Rosenwach, Chief Business Officer at Deerfield Catalyst ? Owen Willis, Founder and General Partner at Opal Ventures ? Kevin Chu, Principal at F-Prime Capital ? Dr. Josh Makower, Director and Co-Founder of the Stanford Byers Center for Biodesign and the Founder and Executive Chairman of ExploraMed ? David Kereiakes, Managing Partner at Windham Capital Partners ? Scott Huennekens, Former Medtech CEO/Entrepreneur, current Investor, & Executive Chairman via Front Foot Ventures
-
-
Windham Capital Partners (#LSIEurope24 Investor) is a growth equity firm based in New York City, specializing in healthcare investments, particularly in therapeutic medical technology and digital health. They assess a company’s likelihood of success based on the 3 following standards: 1. The Leadership Team ? has the right experience, knowledge, expertise and resources ? is honest and realistic about the challenges the company faces 2. The Company ? is beyond the concept development stage ? addresses a large unmet need in healthcare ? addresses a large market and focused on “the next big thing” ? has generated impressive data demonstrating its technology or product works ? understands healthcare economics and can articulate a clear value proposition 3. The Technology or Procedure ? is “evidence-based” ? is either transformative, that is, it offers a totally new way to approach a problem, or clearly superior to any existing product ? is free of intellectual property barriers Windham Capital Partners portfolio includes companies like: ? Andros (Jeff Fritz) ? Earlens Corporation (#LSIAlumni - Bill Facteau) ? Neuspera Medical Inc. (LSI Alumni - Steffen Hovard) ? Nuvaira, Inc. (Dennis Wahr M.D.) ? among others We’re thrilled to welcome David Kereiakes, Managing Partner at Windham Capital Partners to LSI Europe ‘24 this September 16-20th in Sintra, Portugal. Want to see what other investors are joining us at LSI Europe ‘24? Head over to our website to see a preview of the 100+ confirmed investors.
-